SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-10-027292
Filing Date
2010-05-14
Accepted
2010-05-14 13:40:39
Documents
3
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 v185040_10q.htm 10-Q 286335
2 v185040_ex31-1.htm EX-31.1 7180
3 v185040_ex32-1.htm EX-32.1 15982
  Complete submission text file 0001144204-10-027292.txt   311217
Mailing Address 710 POST OAK SUITE 410 HOUSTON TX 77024
Business Address 710 POST OAK SUITE 410 HOUSTON TX 77024 713-780-0806
Oncolin Therapeutics, Inc. (Filer) CIK: 0001229089 (see all company filings)

IRS No.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-50541 | Film No.: 10832117
SIC: 2834 Pharmaceutical Preparations